Dynatronics (DYNT) AI Stock Analysis

• Market Cap: $720.06K
• Dividend Yield: N/A
• Average Volume (3M): 9.46K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.24
• Revenue Growth: -15.80%
• EPS Growth: -65.59%
• Country: US
• Employees: 111
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): -0.56
• Shares Outstanding: 16,001,331
• 10 Day Avg. Volume: 9,367
• 30 Day Avg. Volume: 9,464
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.21
• Price to Sales (P/S): 0.02
• P/FCF Ratio: 2.48
• Enterprise Value/Market Cap: 20.11
• Enterprise Value/Revenue: 0.53
• Enterprise Value/Gross Profit: 2.41
• Enterprise Value/Ebitda: -1.54
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: $0.00 ▼(-100.00% Downside)

Dynatronics' overall stock score is primarily impacted by its weak financial performance and bearish technical indicators. The negative P/E ratio and lack of dividend yield further contribute to a low valuation score. The absence of earnings call data and corporate events means these factors do not influence the score.

Dynatronics Business Overview & Revenue Model

Company Description

Dynatronics Corporation (DYNT) is a manufacturer and distributor of medical devices and products, primarily serving the physical therapy and rehabilitation sectors. The company offers a range of products including therapeutic modalities, rehabilitation equipment, and consumable supplies designed to aid in patient recovery and enhance treatment outcomes. Dynatronics focuses on innovation and quality, providing solutions that cater to healthcare professionals and facilities.

How the Company Makes Money

Dynatronics generates revenue through the sale of its medical devices and therapeutic products. The company's revenue model is primarily based on direct sales to healthcare providers, including hospitals, clinics, and rehabilitation centers. Key revenue streams include the sale of physical therapy equipment, rehabilitation modalities, and disposable medical supplies. Additionally, Dynatronics may engage in partnerships with healthcare organizations and distributors, which can enhance its market reach and contribute to sales growth. The company also benefits from recurring revenue through consumable products that require regular replenishment, thereby creating a steady income stream over time.

Dynatronics Financial Statement Overview

Summary

Dynatronics is facing financial challenges with declining revenues, negative profitability, and high leverage. The company's ability to generate cash is limited, posing risks to financial stability. Strategic improvements are needed to enhance revenue growth and profitability.

Income Statement

Dynatronics has experienced declining revenues over the past few years, with a negative revenue growth rate of -3.64% in the most recent year. The company is struggling with profitability, as indicated by negative net profit margins and EBIT margins. Gross profit margins have also decreased, suggesting challenges in maintaining cost efficiency.

Balance Sheet

The company's balance sheet shows high leverage with a debt-to-equity ratio of 2.03, indicating significant reliance on debt financing. Return on equity is negative, reflecting ongoing losses. The equity ratio is relatively low, suggesting limited equity buffer against liabilities.

Cash Flow

Dynatronics' cash flow situation is concerning, with negative free cash flow growth and low operating cash flow coverage ratio. However, the free cash flow to net income ratio is relatively high, indicating some ability to generate cash relative to reported losses.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	27.39M	27.39M	32.53M	40.61M	44.34M	47.80M
Gross Profit	6.01M	6.01M	7.63M	10.15M	10.67M	12.89M
EBITDA	-9.37M	-9.37M	-976.01K	-3.50M	-2.42M	3.81M
Net Income	-10.90M	-10.90M	-2.70M	-5.66M	-4.73M	1.21M
Balance Sheet
Total Assets	15.44M	15.44M	25.94M	30.06M	35.43M	39.14M
Cash, Cash Equivalents and Short-Term Investments	376.75K	326.34K	483.92K	398.80K	550.11K	6.10M
Total Debt	6.63M	6.63M	6.69M	5.65M	3.84M	5.08M
Total Liabilities	12.18M	12.18M	11.78M	13.21M	13.73M	13.63M
Stockholders Equity	3.26M	3.26M	14.16M	16.86M	21.70M	25.51M
Cash Flow
Free Cash Flow	270.13K	270.13K	-1.85M	185.15K	-5.20M	236.13K
Operating Cash Flow	300.58K	300.58K	-1.61M	372.00K	-4.88M	383.00K
Investing Cash Flow	-30.45K	-30.45K	-243.29K	-187.00K	-319.00K	1.53M
Financing Cash Flow	-427.71K	-427.71K	1.84M	-332.71K	-350.00K	2.02M

Dynatronics Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DYNT, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.06, below the 50-day MA of 0.07, and below the 200-day MA of 0.10, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 31.17 is Neutral, neither overbought nor oversold. The STOCH value of 5.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DYNT.

Dynatronics Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AXGN	―	$836.05M	―	-4.48%	―	17.17%	72.68%
XTNT	―	$112.14M	-22.44	-9.80%	―	15.16%	-39.18%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
NURO	―	―	―	―	―	-48.61%	32.18%
NUWE	―	$2.93M	-0.09	―	―	-7.72%	99.54%
DYNT	―	$720.06K	-0.04	-125.14%	―	-15.80%	-65.59%
HIND	―	$30.16M	―	-101.49%	―	-19.81%	93.32%

Dynatronics Corporate Events

Dynatronics Delays Annual Report Filing

Dynatronics Corporation has announced a delay in filing its Form 10-K (Yearly Report) for the fiscal year ending June 30, 2025. The primary reason for this delay is the additional time required to complete an impairment analysis essential for finalizing the financial statements and related disclosures. The company expects to file the report within the extension period allowed under Rule 12b-25, which is within fifteen calendar days following the original due date. Importantly, Dynatronics does not anticipate any significant changes in its financial results compared to the previous fiscal year. The company remains committed to compliance and transparency, with the notification signed by Brian Baker, the Chief Executive Officer and Chief Financial Officer.